Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug
The tentative approval by the US Food and Drug Administration (USFDA) is for Azilsartan Medoxomil tablets of strengths 40 mg and 80 mg, Zydus Lifesciences said in a regulatory filing.
)
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II. Image source- Pixabay